Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism POU2AF1 inhibitors(POU class 2 homeobox associating factor 1 inhibitors), POU2F1 inhibitors(POU class 2 homeobox 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Discovery | - | 28 Sep 2023 | |
Immune System Diseases | Discovery | - | 28 Sep 2023 | |
Immune System Diseases | Discovery | - | 28 Sep 2023 | |
Other Diseases | Discovery | - | 28 Sep 2023 | |
Other Diseases | Discovery | - | 28 Sep 2023 | |
Other Diseases | Discovery | - | 28 Sep 2023 | |
Respiratory Diseases | Discovery | - | 28 Sep 2023 | |
Respiratory Diseases | Discovery | - | 28 Sep 2023 | |
Respiratory Diseases | Discovery | - | 28 Sep 2023 |